Miravant Medical Technologies Inc. (MRVT)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Breakdown | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -11.52 Million | -10.82 Million | -8.57 Million | -15.24 Million | -13.37 Million | -18.39 Million |
| Net Income | -15.89 Million | -7.46 Million | -15.96 Million | -16.4 Million | -25.99 Million | -22.25 Million |
| Depreciation & Amortization | 346 Thousand | 846 Thousand | 1.7 Million | 1.75 Million | 2.5 Million | 4.14 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -69 Thousand | 241 Thousand | 3.82 Million | -4.55 Million | 3.56 Million | -2.31 Million |
| Other non-cash items | 4.09 Million | -4.45 Million | 1.86 Million | 3.95 Million | 6.55 Million | 2.03 Million |
| Investing Cash Flow | -3.3 Million | 1.31 Million | 4.57 Million | 14.75 Million | -15.77 Million | -4.35 Million |
| Investments in PPE | - | -306 Thousand | - | -287 Thousand | -263 Thousand | -551 Thousand |
| Acquisitions | - | - | - | 863 Thousand | - | - |
| Investment purchases | -2.98 Million | - | -28.67 Million | -43.68 Million | -31.39 Million | -17.01 Million |
| Sales/Maturities of investments | - | 1.58 Million | 33.33 Million | 57.93 Million | 16.11 Million | 13.39 Million |
| Other Investing Activities | -317 Thousand | 28 Thousand | -83 Thousand | 796 Thousand | -232 Thousand | -182 Thousand |
| Financing Cash Flow | 16.91 Million | 9.82 Million | 3.26 Million | 15 Thousand | 11.91 Million | 30.63 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 2.12 Million | 8000.00 | 2.41 Million | - | 4.41 Million | 18.77 Million |
| Other Financing Activities | 14.78 Million | 9.81 Million | 845 Thousand | - | 7.5 Million | 11.86 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | -361 Thousand | - | - |
| Other working capital | - | - | - | -4.19 Million | - | - |
| Cash at beginning of period | 1.03 Million | 723 Thousand | 1.45 Million | 1.93 Million | 19.16 Million | 11.28 Million |
| Cash at end of period | 3.11 Million | 1.03 Million | 723 Thousand | 1.45 Million | 1.93 Million | 19.16 Million |
| Capital Expenditure | - | -306 Thousand | - | -287 Thousand | -263 Thousand | -551 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 2.08 Million | 307 Thousand | -735 Thousand | -477 Thousand | -17.23 Million | 7.88 Million |
| Free Cash Flow | -11.52 Million | -11.13 Million | -8.57 Million | -15.53 Million | -13.63 Million | -18.94 Million |
| Breakdown | 2005 Q3 | 2005 Q2 | 2005 Q1 | 2004 FY | 2004 Q4 | 2004 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -3.48 Million | -4.88 Million | -3.71 Million | -15.89 Million | -3.25 Million | -3.44 Million |
| Depreciation & Amortization | 84 Thousand | 47 Thousand | 50 Thousand | 346 Thousand | 52 Thousand | 61 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -676 Thousand | 1.04 Million | 153 Thousand | -69 Thousand | 342 Thousand | -438 Thousand |
| Other non-cash items | 642 Thousand | 639 Thousand | 720 Thousand | 4.09 Million | 1.02 Million | 679 Thousand |
| Investing Cash Flow | 1.77 Million | -1.18 Million | 1.94 Million | -3.3 Million | 21 Thousand | -88 Thousand |
| Investments in PPE | -155 Thousand | -165 Thousand | -26 Thousand | - | - | - |
| Acquisitions | 2000.00 | - | - | - | - | - |
| Investment purchases | -4 Million | - | - | -2.98 Million | 119 Thousand | -112 Thousand |
| Sales/Maturities of investments | 5.99 Million | 3.13 Million | 1.99 Million | - | - | - |
| Other Investing Activities | -58 Thousand | -4.15 Million | -21 Thousand | -317 Thousand | -98 Thousand | 24 Thousand |
| Financing Cash Flow | - | 7.67 Million | -90 Thousand | 16.91 Million | -222 Thousand | 2.98 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 7.58 Million | 1000.00 | 2.12 Million | -12.87 Million | 2.98 Million |
| Other Financing Activities | - | 95 Thousand | -91 Thousand | 14.78 Million | 12.65 Million | - |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 5.52 Million | 2.18 Million | 3.11 Million | 1.03 Million | 5.14 Million | 5.39 Million |
| Cash at end of period | 3.86 Million | 5.52 Million | 2.18 Million | 3.11 Million | 3.11 Million | 5.14 Million |
| Capital Expenditure | -155 Thousand | -165 Thousand | -26 Thousand | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -1.65 Million | 3.34 Million | -932 Thousand | 2.08 Million | -2.03 Million | -244 Thousand |
| Free Cash Flow | -3.59 Million | -3.31 Million | -2.81 Million | -11.52 Million | -1.83 Million | -3.14 Million |
GALIM
8905
EPR
TEUFF
0351
BTMD